Abstract
Hypertonic saline, insulin and electrolyte replacement are commonly used in the intensive care unit.1-3 Hypertonic saline has several beneficial effects including volume-expanding properties, increased cardiac output, and intracranial pressure reduction.4,5 The electrolytes play a pivotal role in maintaining several metabolic functions and processes.1,6 Appropriate glucose management in the critically ill using insulin infusions has been associated with beneficial outcomes.7-9
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Buckley MS, LeBlanc JM, Cawley MJ. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Crit Care Med. 2010;38(6 Suppl):S253-S264.
Froelich M, Quanhong Ni, Wess C, Ougorets I, Härtl R. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med. 2009;37(4):1433-1441.
Gunst J, Van den Berghe G. Blood glucose control in the intensive care unit: benefits and risks. Semin Dial. 2010;23:157-162.
Bhardwaj A, Ulatowski A. Hypertonic saline solutions in brain injury. Curr Opin Crit Care. 2004;10:126-131.
Strandvik GF. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia. 2009;64:990-1003.
Kraft MD, Btaiche IF, Sacks GS, et al. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. 2005;62:1663-1682.
Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr. 2006;30:164-172.
Lacherade JC, Jacqueminet S, Preiser JC. An overview of hypoglycemia in the critically ill. J Diabetes Sci Technol. 2009;3:1242-1249.
Hashim MK, Issa D, Ahmad Z, Cappuccio JD, Kouides RW, Sterns RH. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol. 2007;2:1110-1117.
Gahart BL, Nazareno AR. Intravenous Medications: A Handbook for Nurses and Health Professionals. 26th ed. St. Louis: Mosby; 2010.
Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug Information Handbook: A Comprehensive Resource for All Clinicians and Healthcare Professionals. 17th ed. Hudson: Lexi-comp; 2008.
Locatelli F, Pontoriero G, Di Filippo S. Electrolyte disorders and substitution fluid in continuous renal replacement therapy. Kidney Int Suppl. 1998;53:S151-S155.
Soupart A, Penninckx R, Stenuit A, Perier O, Decaux G. Treatment of chronic hyponatremia in rats by intravenous saline: comparison of rate versus magnitude of correction. Kidney Int. 1992;41:1662-1667.
Shrishrimal K, Hart P, Michota F. Managing diabetes in hemodialysis patients: observations and recommendations. Cleve Clin J Med. 2009;76:649-655.
Ahmed Z, Simon B, Choudhury D. Management of diabetes in patients with chronic kidney disease. Postgrad Med. 2009;121:52-60.
Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-591.
Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-139.
Dube L, Granry JC. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth. 2003;50:732-746.
Nanji AA. Drug-induced electrolyte disorders. Drug Intell Clin Pharm. 1983;17:175-185.
Dacey MJ. Hypomagnesemic disorders. Crit Care Clin. 2001;17:155-173.
Stoff JS. Phosphate homeostasis and hypophosphatemia. Am J Med. 1982;72:489-495.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Buckley, M.S. (2011). Hypertonic Saline, Electrolytes, and Insulin. In: Kane-Gill, S., Dasta, J. (eds) High-Risk IV Medications in Special Patient Populations. Springer, London. https://doi.org/10.1007/978-0-85729-606-1_5
Download citation
DOI: https://doi.org/10.1007/978-0-85729-606-1_5
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-605-4
Online ISBN: 978-0-85729-606-1
eBook Packages: MedicineMedicine (R0)